ArticleActa medica Philippina2026
The Spectrum of Kidney Disorders in Children Infected with COVID-19: A Retrospective Cohort Study.
Article in Acta medica Philippina, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has impacted various organ systems, including the kidneys, in adults and children. While acute kidney injury (AKI) is well-documented in adults with COVID-19, there is limited data on kidney involvement in pediatric patients, especially in resource-limited settings like the Philippines. This study explores the spectrum of kidney diseases in children infected with COVID-19. Objective: The study aims to characterize the incidence and types of kidney dysfunction in pediatric COVID-19 patients, identify associated risk factors, and evaluate patient outcomes, including the need for renal replacement therapy (RRT) and mortality rates. Methods: This retrospective cohort study analyzed pediatric patients diagnosed with SARS-CoV-2 infection via RT-PCR, admitted to the Philippine General Hospital from March 2020 to April 2023. Patients with prior kidney disease were excluded. Data on demographic characteristics, clinical status, comorbidities, and laboratory findings were collected. Kidney dysfunction was defined as AKI, proteinuria, hematuria, or glucosuria. Associations between kidney dysfunction, COVID-19 severity, and patient outcomes were analyzed using logistic regression. Results: Of the 316 pediatric COVID-19 patients included, 47.78% (151) had kidney involvement, most commonly hematuria (28.48%), proteinuria (26.27%), and AKI (14.60%). Severe and critical COVID-19 were significantly associated with kidney dysfunction, while comorbidities such as oncologic/hematologic conditions decreased the odds of proteinuria and glucosuria. AKI was associated with hypertension, fever, and severe COVID-19. Mortality was 12.03%, with AKI and critical COVID-19 being significant risk factors. Conclusion: Kidney dysfunction is common in pediatric COVID-19 cases, particularly in severe disease. AKI was strongly associated with worse outcomes, including mortality. Early detection and management of kidney involvement are essential to improving prognosis in pediatric COVID-19 patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.